The Brugada syndrome revisited

Area of Science:

• Cardiology
• Genetics
• Electrophysiology

Background:

• Brugada syndrome is a rare but significant cause of sudden cardiac death.
• It is characterized by a genetic defect leading to reduced depolarizing current.
• Emerging evidence suggests structural abnormalities may also contribute in some cases.

Purpose of the Study:

• To summarize the current understanding of Brugada syndrome.
• To highlight diagnostic criteria and risk stratification methods.
• To review current and potential therapeutic interventions.

Main Methods:

• Review of existing literature on Brugada syndrome.
• Analysis of diagnostic criteria including ECG findings and clinical features.
• Evaluation of current management strategies and therapeutic options.

Main Results:

• Diagnosis necessitates a Brugada-type ECG combined with typical clinical manifestations.
• Clinical features are crucial for guiding risk stratification and patient management.
• Implantable cardioverter defibrillators (ICDs) remain the sole intervention with strong evidence.

Conclusions:

• Effective risk stratification is essential for rational Brugada syndrome management.
• Pharmacological therapies are under investigation but lack robust evidence.
• Further research is needed to improve risk assessment and therapeutic approaches.